LifeMD, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 25, 2025 to Discuss Your Rights - LFMD
Levi & Korsinsky is investigating a class action lawsuit against LifeMD, Inc. (LFMD) for alleged securities fraud between May 7 and August 5, 2025.Summary
Levi & Korsinsky, LLP has announced a class action securities lawsuit against LifeMD, Inc. (NASDAQ: LFMD) on behalf of investors who experienced losses between May 7, 2025, and August 5, 2025. The lawsuit alleges that the defendants made false and/or misleading statements regarding LifeMD's competitive position and financial guidance. Specifically, the complaint claims that the defendants overstated the company’s competitive position and were reckless in raising their 2025 guidance without properly accounting for rising customer acquisition costs, particularly within the RexMD segment and related to obesity drugs like Wegovy and Zepbound. Investors who suffered losses during this period have until October 25, 2025, to potentially be appointed as lead plaintiff. Participation is free, and investors may be entitled to compensation without out-of-pocket costs. Levi & Korsinsky has a strong track record in securities litigation, consistently ranking among the top firms in the United States.
(Source：GuruFocus)